Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in TaxesChange in TaxesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Asset Writedowns and Impairment (2021 - 2023)

Evotec SE's Asset Writedowns and Impairment history spans 2 years, with the latest figure at -$5520.6 for Q4 2023.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to -$5520.6 in Q4 2023 year-over-year; TTM through Dec 2023 was -$11611.2, a N/A change, with the full-year FY2025 number at $927742.7, down 92.88% from a year prior.
  • Asset Writedowns and Impairment hit -$5520.6 in Q4 2023 for Evotec SE, down from -$13.06 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for EVO hit a ceiling of -$13.06 in Q3 2023 and a floor of -$5520.6 in Q4 2023.